Mark Chiboroski

Title: Mark Chiboroski: Innovator in Chromatographic Processes

Introduction

Mark Chiboroski is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of chromatography, particularly in the production of heterodimeric proteins. His innovative approaches have the potential to enhance product yield and purity in large-scale commercial applications.

Latest Patents

Mark Chiboroski holds a patent for "Methods for removing undesired components during multistage chromatographic processes." This patent focuses on high-resolution affinity chromatography that combines affinity resolving and affinity capture processes using a single chromatography matrix. This method results in improved resolution between closely related molecular species and significantly enhances overall product yield for large-scale commercial production of bispecific antibodies. Additionally, the process reduces tankage and equipment requirements by allowing for lower salt concentrations while increasing product purity and concentration, all without the need for dilution, ultrafiltration, or diafiltration.

Career Highlights

Chiboroski is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in chromatography to advance biopharmaceutical production. His work has been instrumental in developing methods that streamline processes and improve efficiency in the production of complex proteins.

Collaborations

Mark collaborates with talented colleagues such as Travis Tran and Andrew Tustian. Their combined efforts contribute to the innovative environment at Regeneron Pharmaceuticals, fostering advancements in biopharmaceutical technologies.

Conclusion

Mark Chiboroski's contributions to chromatography and biopharmaceutical production exemplify the impact of innovative thinking in the field. His patent and work at Regeneron Pharmaceuticals highlight the importance of advancements in technology for improving product yield and purity.